News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,038 Results
Type
Article (14431)
Company Profile (114)
Press Release (349493)
Section
Business (112621)
Career Advice (456)
Deals (18612)
Drug Delivery (28)
Drug Development (31172)
Employer Resources (50)
FDA (8792)
Job Trends (7672)
News (172738)
Policy (12355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1320)
Allergies (38)
Alliances (34771)
ALS (22)
Alzheimer's disease (502)
Antibody-drug conjugate (ADC) (62)
Approvals (8812)
Artificial intelligence (225)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (108)
Cancer (946)
Cardiovascular disease (58)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (256)
Cervical cancer (10)
Clinical research (24421)
Collaboration (565)
Compensation (102)
Complete response letters (3)
COVID-19 (1146)
CRISPR (34)
C-suite (130)
Cystic fibrosis (47)
Data (902)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (93)
Diagnostics (4895)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (72)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38563)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51118)
Executive appointments (361)
FDA (9363)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (446)
Gene editing (80)
Generative AI (23)
Gene therapy (160)
GLP-1 (221)
Government (1232)
Grass and pollen (1)
Guidances (23)
Healthcare (9891)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (28)
Indications (11)
Infectious disease (1217)
Inflammatory bowel disease (60)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (51)
IPO (8002)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (114)
Leadership (3)
Legal (2520)
Liver cancer (34)
Lung cancer (120)
Lymphoma (56)
Machine learning (2)
Management (17)
Manufacturing (166)
MASH (15)
Medical device (11451)
Medtech (11456)
Mergers & acquisitions (10930)
Metabolic disorders (201)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (25)
Neuropsychiatric disorders (3)
Neuroscience (678)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1021)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (46)
Pancreatic cancer (38)
Parkinson's disease (62)
Partnered (11)
Patents (129)
Patient recruitment (48)
Peanut (26)
People (32672)
Pharmaceutical (16)
Phase I (9008)
Phase II (11018)
Phase III (7152)
Pipeline (486)
Podcasts (36)
Policy (26)
Postmarket research (501)
Preclinical (4064)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (130)
Real estate (3358)
Recruiting (20)
Regulatory (9326)
Reports (18)
Research institute (1269)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (2)
RSV (21)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (17)
Southern California (1111)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (2)
Supply chain (22)
The Weekly (17)
United States (10771)
Vaccines (307)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (102)
Last 7 days (321)
Last 30 days (1372)
Last 365 days (17704)
2025 (4166)
2024 (18710)
2023 (22098)
2022 (30813)
2021 (32512)
2020 (30537)
2019 (25794)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12743)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (119)
Arkansas (10)
Asia (24000)
Australia (4178)
California (2675)
Canada (981)
China (227)
Colorado (154)
Connecticut (126)
Delaware (37)
Europe (49022)
Florida (441)
Georgia (130)
Idaho (33)
Illinois (264)
India (10)
Indiana (152)
Iowa (4)
Japan (100)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (431)
Massachusetts (1880)
Michigan (179)
Minnesota (240)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (846)
New Mexico (16)
New York (797)
North Carolina (503)
North Dakota (7)
Northern California (1021)
Ohio (99)
Oklahoma (11)
Oregon (19)
Pennsylvania (550)
Puerto Rico (7)
Rhode Island (20)
South America (505)
South Carolina (16)
South Dakota (1)
Southern California (1111)
Tennessee (54)
Texas (434)
Utah (99)
Virginia (52)
Washington D.C. (11)
Washington State (311)
West Virginia (3)
Wisconsin (35)
364,038 Results for "biostem technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
March 28, 2025
·
1 min read
Press Releases
BioStem Announces Notice of Allowance for Two U.S. Patent Applications
April 1, 2025
·
5 min read
Press Releases
BioStem Technologies CEO to Present at Biotech Showcase 2025
January 2, 2025
·
4 min read
Press Releases
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers
February 25, 2025
·
7 min read
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
BioStem Technologies Inc. today announced that an article validating its proprietary processing method and its placental allograft products has been published in the international, peer-reviewed journal, Health Science Reports.
June 26, 2024
·
5 min read
Business
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeStrategic Audit Completion Set to Enhance BioStem Technologies’ Market Position and Shareholder Value
BioStem Technologies Inc. today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023.
April 24, 2024
·
5 min read
Press Releases
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
January 9, 2025
·
7 min read
Policy
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
BioStem Technologies Inc. announced that the United States Patent and Trademark Office has granted the Company’s request for Prioritized Examination for its application for U.S. Patent 18/290,914.
May 6, 2024
·
4 min read
BioMidwest
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies Inc. announced that it has retained the services of Mr. Nick McCoy, who will lead BioStem’s Diabetic Foot Ulcer and Venous Leg Ulcer clinical trials process as a consultant to the Company.
April 30, 2024
·
5 min read
Business
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, reported financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
12 min read
1 of 36,404
Next
